Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SHS NEW
-
Total 13F shares
-
1,895,159
-
Share change
-
+1,887,659
-
Total reported value
-
$40,195,000
-
Price per share
-
$21.21
-
Number of holders
-
14
-
Value change
-
+$40,035,000
-
Number of buys
-
13
Institutional Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q2 2021
As of 30 Jun 2021,
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,895,159 shares.
The largest 10 holders included
Roumell Asset Management, LLC, INVESTMENT MANAGEMENT OF VIRGINIA LLC, VILLERE ST DENIS J & CO LLC, FRIESS ASSOCIATES LLC, STATE STREET CORP, BENJAMIN F. EDWARDS & COMPANY, INC., Weil Company, Inc., RAYMOND JAMES & ASSOCIATES, CITADEL ADVISORS LLC, and ACT Capital Management, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.